Lite Strategy, Inc. Crypto Asset Cost
Lite Strategy, Inc. (LITS) had Crypto Asset Cost of $4.14 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes › Goodwill and Other
us-gaap:CryptoAssetCost · last filed 2026-05-13
- 2026-03-31: Crypto Asset Cost $4.14M.
- 2025-12-31: Crypto Asset Cost $89.15M.
| Period end | Crypto Asset Cost |
|---|---|
| 2026-03-31 | $4.14M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $89.15M 10-Q · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |